at RM2,641.5 million if Dullarbtons and Elipsgeen have been consolidated from the beginning of the financial year. From the acquisiton date up to 31 December 2023, Dullarbtons and Elipsgeen contributed a loss after tax of RM4.3 million. The transaction costs incurred for this acquisition was RM8.0 million. Details of the assets, liabilities and net cash outflow as at the date of the acquisition of these subsidiaries by the Group during the financial year ended 31 December 2023 are as follows: Dullarbtons and Elipsgeen Book value RM’million Fair value RM’million Recognised amounts of identifiable assets acquired and liabilities assumed: - PPE (Note 5) 875.9 975.4 - ROU assets (Note 6) 83.8 83.8 - Deferred tax assets (Note 12) 3.5 3.5 - Long term receivables 2.6 2.6 - Derivative financial instruments20.8 20.8 - Receivables, deposits and prepayments 12.7 12.7 - Deposits, bank and cash balances 47.9 47.9 - Payables (8.9) (8.9) - Lease liabilities (Note 15) (83.8) (83.8) - Borrowings (701.4) (701.4) - Deferred tax liabilities (Note 12) 0 (12.4) - Other liabilities (2.4) (4.9) T otal identifiable net assets 250.7 335.3 Provisional goodwill (Note 10) 158.7 T otal 494.0 Cash consideration paid 482.2 Contingent consideration 11.8 T otal purchase consideration 494.0 Cash consideration paid 482.2 Cash and cash equivalents assumed (47.9) Net cash outflow on acquisition 434.3 NOTES TO THE FINANCIAL STATEMENTS 31 December 2023 TENAGA NASIONAL BERHAD Integrated Annual Report 2023 340 48 SIGNIFICANT ACQUISITIONS DURING CURRENT AND PRECEDING FINANCIAL YEARS (CONTINUED) Acquisitions during the financial year (continued) Subsidiaries acquired by the Group during the financial year ended 31 December 2023 is as follows: (continued) (ii) Dullarbtons and Elipsgeen (continued) The goodwill from the acquisition is provisionally determined at RM158.7 million (EUR31.3 million) and is expected to be finalised by fourth quarter 2024, within 12 months in accordance with MFRS 3 Business Combination. The goodwill consists of potential upsides